Glycemic and hypoglycemia treatment targets should be individualized and reassessed every 3–6 months. If targets are not met, one diabetes technology—continuous subcutaneous insulin infusion ...

Diabetic hypoglycemia occurs when a person's blood sugar level falls too low. Symptoms can include: shakiness, confusion or ...

The FDA's Orphan Drug Designation is intended to encourage the development of treatments for rare diseases. Orphan Drug Designation offers benefits including seven years of market exclusivity ...

and transplant interventions in patients with T1D complicated by problematic hypoglycemia (Table 2) and to propose clinical practice recommendations (Table 3) in a tiered, four-stage treatment ...

Tumor HI is a rare condition that results in hypoglycemia caused by either islet cell tumors (eg, insulinomas) or non-islet cell tumors (eg, hepatocellular carcinoma).

Hypoglycemia is the major barrier to good glycemic control in patients with diabetes mellitus. Furthermore, randomized controlled trials have emphasized the grave risks associated with severe ...

The tumor was resected with cure of symptoms. A 41-year-old Maltese woman was referred to a specialist center for evaluation of fasting hypoglycemia. The patient reported a 12-month history of ...

Immediate treatment for such low blood sugar levels is important. You can either eat food or take glucose tablets. If you have diabetes, you are more likely to have episodes of hypoglycemia or low ...

Rezolute, Inc. (RZLT),a late-stage biopharmaceutical company, Tuesday said that the U.S. Food and Drug Administration or FDA has ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced the design of its pivotal Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class ...

Rezolute, Inc. RZLT announced that the FDA has granted an Orphan Drug Designation (“ODD”) to its lead pipeline candidate, ...

Rezolute received an orphan-drug designation from the Food and Drug Administration for its treatment of hypoglycemia, or low blood sugar, caused by a disease in which a tumor produces too much insulin ...